Situation: CMS activity is tightening the operating environment for risk-bearing organizations on three fronts: payment integrity, performance measurement, and episode-based care. CMS reportedly moved to block 11 DME suppliers from Medicare Advantage and Part D payments tied to $3.4 billion in suspected fraudulent billing, reinforcing that Revenue Cycle & Integrity is now central to VBC economics, not a back-office compliance issue (Wakely). At the same time, MA plans received draft 2027 Star Ratings cutpoints, with roughly half of thresholds becoming harder to reach—raising the bar for bonus revenue, quality operations, and member experience execution (MA Stars; Quality Metrics).

The delivery-side signal is equally concrete: stakeholders are parsing new CMS orthopedic and episode policies, especially implications for TEAM and post-acute partners such as home health (TEAM opportunity; Ortho policy). In parallel, the Health Care Transformation Task Force submitted comments on the CY 2027 Physician Fee Schedule and Medicare Shared Savings Program, pressing CMS to strengthen primary care and accountable care infrastructure (HCTTF comments; Value-Based Contracting).

Background: The Trump administration’s CMS—under Administrator Dr. Mehmet Oz, with Abe Sutton leading CMMI—is operating in a market where MA margins, Stars revenue, risk adjustment scrutiny, and fraud enforcement are converging. Plans that once relied on scale and coding sophistication are being forced to prove operational durability. That is why UnitedHealth’s CFO framing that prior “tough decisions” in MA are paying off matters: benefit design, county exits, network discipline, and Star remediation are becoming core strategy rather than episodic fixes (UnitedHealth MA).

Provider-sponsored and regional plans are making the opposite bet from retreating national competitors. Health Alliance Plan, tied to Henry Ford, is publicly doubling down on Medicare Advantage as a long-term payer-provider integration strategy (HAP MA; VBC Market Dynamics). Meanwhile, Medicaid work requirement implementation and school Medicaid concerns add pressure to access-sensitive populations, making attribution stability, eligibility churn, and care management continuity harder for organizations managing total cost of care (Medicaid work rules; Health Equity & SDoH).

Assessment: The through-line is unmistakable: CMS is making risk harder, cleaner, and more operationally demanding. The agency is not retreating from VBC; it is narrowing tolerance for weak controls, loose post-acute networks, inflated utilization, and quality performance that depends on favorable thresholds rather than durable execution. The DME action should be read as a warning to MA plans, ACOs, and delegated medical groups: vendor exposure is now balance-sheet exposure. Fraudulent or medically unnecessary utilization in downstream networks will increasingly threaten bids, Stars, shared savings, and regulatory standing (OIG exclusion; Policy & Regulatory Changes).

The second pattern is the rise of specialty and post-acute accountability. TEAM and orthopedic policy attention show CMS is pushing beyond primary-care-only accountable care into episodes where discharge planning, home health readiness, and referral management determine cost variance (Care Coordination). But the home-based care market is strained by higher acuity and intake bottlenecks, meaning hospitals and ACOs cannot assume post-acute capacity will absorb risk without investment (Home-based acuity).

My read: organizations with integrated payer-provider assets, disciplined vendor governance, and real-time quality operations will gain share. Those treating MA, MSSP, and bundles as separate businesses will underperform.